Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2026-02-25 @ 7:28 PM
Study NCT ID:
NCT01087294
Status:
COMPLETED
Last Update Posted:
2025-11-21
First Post:
2010-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08-04
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-02
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-13
First Submit QC Date:
None
Study First Post Date:
2010-03-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-11-21
Last Update Post Date Type:
ESTIMATED